title: Delayed graft function of cadaveric renal transplants is prevented by diltiazem.
authors.affiliation: Istituto di Chirurgia Generale e Sperimentale, Universitá degli Studi di Pisa, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Carmellini
authors.forename: M
authors.initials: M
authors.lastname: Salvadori
authors.forename: R
authors.initials: R
authors.lastname: Di Stefano
authors.forename: E
authors.initials: E
authors.lastname: Bertoni
authors.forename: G
authors.initials: G
authors.lastname: Nicita
authors.forename: A
authors.initials: A
authors.lastname: Rosati
authors.forename: G
authors.initials: G
authors.lastname: Taddei
authors.forename: P
authors.initials: P
authors.lastname: Rindi
authors.forename: G
authors.initials: G
authors.lastname: Rizzo
authors.forename: F
authors.initials: F
authors.lastname: Mosca
mesh_terms: D000328:Adult; D002102:Cadaver; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D004110:Diltiazem / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000628:therapy; D006085:Graft Survival / Q000187:drug effects*; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000502:physiology*; D008297:Male; D016853:Muromonab-CD3 / Q000627:therapeutic use; D012189:Retrospective Studies; D014184:Transplantation, Homologous; D017211:Treatment Failure
chemical_list: D002121:Calcium Channel Blockers; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D004110:Diltiazem